In a promising advance in its fight against cervical cancer, India recently launched its first locally produced version of the human papillomavirus (HPV) vaccine “Cervavac”. Currently, India lacks a national immunization program for carcinoma cervix er
In India, cervical cancer associated with human papillomavirus (HPV) infection is a leading cause of cancer-related mortality among women. However, uptake of the vaccine in India is low. We assessed knowledge and attitudes towards HPV, assess participants' willingness to accept the vaccination for ...
Indian Cancer Society (HPV Vaccine Film): Regia di Jyoti Kapur Das. Con Garima Goel, Anurita Jha, Santosh Singh, Chahat Tewani.
参考资料 [1] Basu,Partha, et al. "Vaccine efficacy against persistent human papillomavirus(HPV) 16/18 infection at 10 years after one, two, and three doses ofquadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohortstudy." The Lancet Oncology 22.11 (2021): 1518-1529. ...
[1]Basu,Partha, et al. "Vaccine efficacy against persistent human papillomavirus(HPV) 16/18 infection at 10 years after one, two, and three doses ofquadrivalent HPV vaccine in girls in India: a multicentre, prospect...
launched a project to introduce the HPV vaccine in India after collaborating with the Indian Council of Medical Research. In April 2010, the government had to suspend the national HPV vaccination project as a result of pressure from...
(2010). HPV vaccine suspension in India. The Lancet, 376(9753), 1644-1645.、 [15] Colombara, D. V., & Wang, S. M. (2013). The impact of HPV vaccination delays in China: lessons from HBV control programs. Vaccine, 31(38), 4057. [16] Hall, M. T., Simms, K. T., Lew...
[2] Basu,Partha, et al. "Vaccine efficacy against persistent human papillomavirus(HPV) 16/18 infection at 10 years after one, two, and three doses ofquadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohortstudy." The Lancet Oncology 22.11 (2021): 1518-1529. ...
Background Cervical cancer is a leading cause of cancer-associated mortality among women in India, with 96,922 new cases and 60,078 deaths each year, almost one-fifth of the global burden. In 2018, Sikkim state in India introduced human papillomavirus (HPV) vaccine for 9–13-year-old girls...
at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: ...